Type 2 Diabetes Accounts for the Largest Share of the GLP-1 Market Based on the target indication, the market is segmented into Alzheimer's Disease, non-alcoholic steatohepatitis, obesity, sleep apnea, and type 2 diabetes
For example, a review article in the New England Journal of Medicine describes the numerous benefits of intermittent fasting beyond weight loss, including improved cellular function and resistance to stress and reduced inflammation
Well review your health background, discuss your goals, and determine the right starting plan
PlexusDx's Precision Peptide Genetic Test analyzes key variantsincluding GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313that correlate with appetite regulation and weight loss outcomes
Davies, M., Faerch, L., Jeppesen, O
Giovanna Traina